Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies.
about
Head injury at early ages is associated with risk of Parkinson's diseaseParkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.Pesticides and Parkinson's disease--is there a link?Estrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K(+) channel.Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.Gene-environment interactions: key to unraveling the mystery of Parkinson's diseaseDisease-toxicant interactions in Parkinson's disease neuropathologyEffects of gender on nigral gene expression and parkinson disease.Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration.Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson diseaseNeuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.Imbalanced estrogen metabolism in the brain: possible relevance to the etiology of Parkinson's diseaseLower low-density lipoprotein cholesterol levels are associated with Parkinson's diseaseThe association between Mediterranean diet adherence and Parkinson's diseaseInflammation as a causative factor in the aetiology of Parkinson's diseaseProlonged toxicokinetics and toxicodynamics of paraquat in mouse brain.Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model.Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cellsNeuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic interventionNeuroinflammation in Parkinson's disease.Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.The Prevalence and Distribution of Neurodegenerative Compound-Producing Soil Streptomyces spp.The potential role of neuroinflammation and transcription factors in Parkinson diseaseParkinson's disease: general features, effects of levodopa treatment and future directions.Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson's DiseaseToxin-induced and genetic animal models of Parkinson's diseaseProtective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases2,5-Hexanedione induces dopaminergic neurodegeneration through integrin αMβ2/NADPH oxidase axis-mediated microglial activation.
P2860
Q24170146-2F30E073-1F15-4A3B-8942-3A469A20C988Q24815148-24CE4B8F-7512-4A2A-8875-E69414E6C2CFQ25257240-9566356E-C526-41FC-A4F3-74930710288FQ27333476-1407E6FC-3E5F-4CD6-B981-18579BBEB6F6Q27686808-C3142B8B-0302-43AC-9060-19F9D3F02F36Q28388674-A6A8D947-1E83-4F7C-9657-B105C22554B2Q29248297-5D165F0B-55E0-438E-90FF-919AC08C3B7FQ33281319-F7F68194-DEE2-41F9-9967-8273FD1EF4C3Q33470625-7016C6A4-A4AF-4152-A945-2533845D3703Q33508801-D4047241-BBB4-4679-A086-F03C21CF4896Q34591684-65AF406D-37AC-40C8-948F-82172427606AQ35044751-5D2F7C60-9CBC-48A0-9868-96E321D3D3ECQ35124298-5D302E55-7916-4966-B933-A8B9B15EF07FQ35869176-44587053-0175-484B-B0A8-F6F0D6C4AAFDQ35951607-3EFAD29D-E544-4700-8792-0C4A9069D6A2Q36052641-7F6356B2-97FA-4083-9578-DB7E637DF12AQ36064964-CDA5511D-77E0-4144-835D-68353E08FEE8Q36085162-A4849938-21D2-4158-9DEA-BBEE255CC80DQ36393015-31E2C61B-DE32-43DD-B33C-90A51EF546D8Q36727515-B1B9783C-35EA-4BE2-87C5-8164D212B5C1Q36919403-48CA402F-94B9-4ACE-9BE8-86FC3C7DCE0FQ37079115-9DE937DA-0F5E-4170-A97E-5B76EAF65821Q37241917-6B814733-2EA5-477E-A692-69653C1235AAQ37653023-156DC102-16B2-4E92-85AB-D6AA77D35CCEQ38743414-CEC41E89-A2F0-422D-88F2-63E30BBBB0C1Q39342497-023C119D-0663-43A9-A915-8C0D54C460F0Q39811364-92643D0C-CF4B-4C13-A6A2-EFED584CE304Q40139530-9F952C10-19E6-491A-9723-64248CFDB020Q41161445-7AACE048-3854-4F09-A27B-A88F550C537CQ41605202-D62B832E-0A2B-491B-9940-784525C42A1EQ41863882-2B1F5820-B2B3-4D55-A62E-2D74796D301BQ49910338-9FE15818-77D4-411A-8B31-AC7D7321BF3B
P2860
Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Is the cause of Parkinson's di ...... y? Evidence from twin studies.
@ast
Is the cause of Parkinson's di ...... y? Evidence from twin studies.
@en
type
label
Is the cause of Parkinson's di ...... y? Evidence from twin studies.
@ast
Is the cause of Parkinson's di ...... y? Evidence from twin studies.
@en
prefLabel
Is the cause of Parkinson's di ...... y? Evidence from twin studies.
@ast
Is the cause of Parkinson's di ...... y? Evidence from twin studies.
@en
P1476
Is the cause of Parkinson's di ...... ry? Evidence from twin studies
@en
P2093
Caroline M Tanner
P304
P577
2003-01-01T00:00:00Z